Cost-effectiveness of targeting patients undergoing cardiac surgery for therapy with intravenous amiodarone to prevent atrial fibrillationElizabeth M. Mahoney, William S. Weintraub, Jovonne K. Williams et al.|Journal of the American College of Cardiology|2002Cited by 134
Long-Term Cost Effectiveness of Early and Sustained Dual Oral Antiplatelet Therapy With Clopidogrel Given for Up to One Year After Percutaneous Coronary InterventionSean C. Beinart, William S. Weintraub, Zefeng Zhang et al.|Journal of the American College of Cardiology|2005Cited by 122
Percutaneous coronary intervention outcomes in octogenarians during the stent era (National Cardiovascular Network)William Weintraub, Elizabeth M. Mahoney, Emir Veledar et al.|The American Journal of Cardiology|2001Cited by 37
Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trialWilliam S. Weintraub, Koon Teo, Stan Kaufman et al.|American Heart Journal|2006Cited by 26